A Return to Trade Secrecy?
What There Is To License and How.
Stephen Y. Chow, Esq., Burns & Levinson LLP
Anthony “Tony” Shull, Esq., Axiom Attorney, Blueprint Medicines Corporation
With successful patent subject matter challenges to computer-related inventions, diagnostics and purified natural DNA segments, is it time to return to the 1970’s reliance on trade secrecy instead of patents? Is this encouraged by the America Invents Act expansion of prior use rights and support of secret use?
The Judiciary Committee of the U.S. Senate unanimously reported a bill (S. 1890) creating a federal private right of action for “misappropriation” of trade secrets, similar to a bill reported in the last session by House Judiciary.
Please join us for a briefing of legal developments affecting and best practices for intellectual property portfolio and business developers including those in the tech and life sciences spaces.
Stephen Y. Chow holds an A.B. cum laude in Physics and an S.M. in applied physics from Harvard University and a J.D. (Stone Scholar) from Columbia University. Primarily a business litigator, starting in 1976 defending IBM from trade secret charges by Xerox, he also prosecutes patents and acts as general counsel to technology start-ups. Steve is a Massachusetts Uniform Law Commissioner (since 1994), trying to enact the Uniform Trade Secrets Act in Massachusetts and a member of the IEEE-USA IP Committee. He is a member of the American Bar Association’s Cybersecurity Task Force.
Anthony “Tony” Shull
holds a B.A. from American University, a J.D. from Suffolk University Law School and a Certificate in Healthcare Compliance from Seton Hall Law School. Tony has litigated trade secrets disputes in private practice in Chicago and has a wealth of experience across industries as a contract attorney to Hasbro, Analog Devices, Inc., Biogen Idec, Sunovion Pharmaceuticals, E Ink Corp. and currently as Axiom Attorney for Blueprint Medicines Corporation.
LES Member: $25